Jennifer Williams

Jennifer Williams

Auto-generated profile, based on publicly available information

Jennifer Williams

University of Kansas Health System

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Stroke
Verified
Journal Article
Open access
PDF file
AFAndria L. Ford
Andria L. Ford
JWJennifer A. Williams
Jennifer A. Williams
MSMary Spencer
Mary Spencer
CMCraig McCammon
Craig McCammon
NKNaim Khoury
Naim Khoury
JLJin-Moo Lee
Jin-Moo Lee
Background and Purpose—: Earlier tissue-type plasminogen activator (tPA) treatment for acute ischemic stroke increases efficacy, prompting national efforts to reduce door-to-needle times. We used lean process improvement methodology to develop a streamlined intravenous tPA protocol. Methods—: In early 2011, a multidisciplinary team analyzed the steps required to treat patients with acute ischemic stroke with intravenous tPA using value stream analysis (VSA). We directly compared the tPA-treated patients in the “pre-VSA” epoch with the “post-VSA” epoch with regard to baseline characteristics, protocol metrics, and clinical outcomes. Results—: The VSA revealed several tPA protocol inefficiencies: routing of patients to room, then to CT, then back to the room; serial processing of workflow; and delays in waiting for laboratory results. On March 1, 2011, a new protocol incorporated changes to minimize delays: routing patients directly to head CT before the patient room, using parallel process workflow, and implementing point-of-care laboratories. In the pre and post-VSA epochs, 132 and 87 patients were treated with intravenous tPA, respectively. Compared with pre-VSA, door-to-needle times and percent of patients treated ≤60 minutes from hospital arrival were improved in the post-VSA epoch: 60 minutes versus 39 minutes ( P <0.0001) and 52% versus 78% ( P <0.0001), respectively, with no change in symptomatic hemorrhage rate. Conclusions—: Lean process improvement methodology can expedite time-dependent stroke care without compromising safety.

18 March 2015 in Journal of Communication in Healthcare
Verified
Journal Article
Closed access
RGRichard T. Griffey
Richard T. Griffey
NSNicole Shin
Nicole Shin
SJSolita Jones
Solita Jones
NANnenna Aginam
Nnenna Aginam
MGMaureen Gross
Maureen Gross
KKKimberly A. Kaphingst
Kimberly A. Kaphingst
Objective Recommended as a ‘universal precaution’ for improving provider–patient communication, teach-back has a limited evidence base. Discharge from the emergency department (ED) to home is an important high-risk transition of care with potential for miscommunication of critical information. We examined whether teach-back improves: comprehension and perceived comprehension of discharge instructions and satisfaction among patients with limited health literacy (LHL) in the ED. Methods We performed a randomized, controlled study among adult patients with LHL, randomized to teach-back or standard discharge instructions. Patients completed an audio-recorded structured interview evaluating comprehension and perceived comprehension of (1) diagnosis, (2) ED course, (3) post-ED care, and (4) reasons to return and satisfaction using four Consumer Assessment of Healthcare Providers and Systems questions. Concordance with the medical record was rated using a five-level scale. We analyzed differences between groups using multivariable ordinal logistic regression. Results Patients randomized to receive teach-back had higher comprehension of post-ED care areas: post-ED medication (P < 0.02), self-care (P < 0.03), and follow-up instructions (P < 0.0001), but no change in patient satisfaction or perceived comprehension. Conclusion Teach-back appears to improve comprehension of post-ED care instructions but not satisfaction or perceived comprehension. Our data from a randomized, controlled study support the effectiveness of teach-back in a busy clinical setting. Further research is needed to test the utility and feasibility of teach-back for routine use including its impacts on distal outcomes.

1 April 2015 in Stroke
Verified
Journal Article
Closed access
PDF file
HAHongyu An
Hongyu An
AFAndria L. Ford
Andria L. Ford
YCYasheng Chen
Yasheng Chen
HZHongtu Zhu
Hongtu Zhu
RPRosana Ponisio
Rosana Ponisio
WLWeili Lin
Weili Lin
Background and Purpose—: Penumbral biomarkers promise to individualize treatment windows in acute ischemic stroke. We used a novel magnetic resonance imaging approach that measures oxygen metabolic index (OMI), a parameter closely related to positron emission tomography–derived cerebral metabolic rate of oxygen utilization (CMRO2), to derive a pair of ischemic thresholds: (1) an irreversible-injury threshold that differentiates ischemic core from penumbra and (2) a reversible-injury threshold that differentiates penumbra from tissue not-at-risk for infarction. Methods—: Forty patients with acute ischemic stroke underwent magnetic resonance imaging at 3 time points after stroke onset: <4.5 hours (for OMI threshold derivation), 6 hours (to determine reperfusion status), and 1 month (for infarct probability determination). A dynamic susceptibility contrast method measured cerebral blood flow, and an asymmetrical spin echo sequence measured oxygen extraction fraction, to derive OMI (OMI=cerebral blood flow×oxygen extraction fraction). Putative ischemic threshold pairs were iteratively tested using a computation-intensive method to derive infarct probabilities in 3 tissue groups defined by the thresholds (core, penumbra, and not-at-risk tissue). An optimal threshold pair was chosen based on its ability to predict infarction in the core, reperfusion-dependent survival in the penumbra, and survival in not-at-risk tissue. The predictive abilities of the thresholds were then tested within the same cohort using a 10-fold cross-validation method. Results—: The optimal OMI ischemic thresholds were found to be 0.28 and 0.42 of normal values in the contralateral hemisphere. Using the 10-fold cross-validation method, median infarct probabilities were 90.6% for core, 89.7% for nonreperfused penumbra, 9.95% for reperfused penumbra, and 6.28% for not-at-risk tissue. Conclusions—: OMI thresholds, derived using voxel-based, reperfusion-dependent infarct probabilities, delineated the ischemic penumbra with high predictive ability. These thresholds will require confirmation in an independent patient sample.

1 July 2012 in Journal of Emergency Nursing
Verified
Journal Article
Closed access
MCMelanie Crowley
Melanie Crowley
CBCarla Brim
Carla Brim
JPJean Proehl
Jean Proehl
SBSusan Barnason
Susan Barnason
SLSherry Leviner
Sherry Leviner
APAnnMarie Papa
AnnMarie Papa

1 January 2011 in Journal of Emergency Nursing
Verified
Journal Article
Closed access
GCGarrett K. Chan
Garrett K. Chan
SBSusan Barnason
Susan Barnason
CDCynthia L. Dakin
Cynthia L. Dakin
GGGordon Lee Gillespie
Gordon Lee Gillespie
MKMary C. Kamienski
Mary C. Kamienski
SLSuling Li
Suling Li

1 April 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
MGManu S. Goyal
Manu S. Goyal
BHBrian G. Hoff
Brian G. Hoff
JWJennifer Williams
Jennifer Williams
NKNaim Khoury
Naim Khoury
RWRebecca Wiesehan
Rebecca Wiesehan
AFAndria L. Ford
Andria L. Ford
Background and Purpose—: Stroke mimics (SM) challenge the initial assessment of patients presenting with possible acute ischemic stroke (AIS). When SM is considered likely, intravenous tissue-type plasminogen activator (tPA) may be withheld, risking an opportunity to treat AIS. Although computed tomography is routinely used for tPA decision making, magnetic resonance imaging (MRI) may diagnose AIS when SM is favored but not certain. We hypothesized that a hyperacute MRI (hMRI) protocol would identify tPA-eligible AIS patients among those initially favored to have SM. Methods—: A streamlined hMRI protocol was designed based on barriers to rapid patient transport, MRI acquisition, and post-MRI tPA delivery. Neurologists were trained to order hMRI when SM was favored and tPA was being withheld. The use of hMRI for tPA decision making, door-to-needle times, and outcomes were compared before hMRI implementation (pre-hMRI: August 1, 2011 to July 31, 2013) and after (post-hMRI, August 1, 2013, to January 15, 2015). Results—: Post hMRI, 57 patients with suspected SM underwent hMRI (median MRI-order-to-start time, 29 minutes), of whom, 11 (19%) were diagnosed with AIS and 7 (12%) received tPA. Pre-hMRI, no tPA-treated patients were screened with hMRI. Post hMRI, 7 of 106 (6.6%) tPA-treated patients underwent hMRI to aid in decision making because of suspected SM (0% versus 6.6%; P =0.001). To ensure standard care was maintained after implementing the hMRI protocol, pre- versus post-hMRI tPA-treated cohorts were compared and did not differ: door-to-needle time (39 versus 37 minutes; P =0.63), symptomatic hemorrhage rate (4.5% versus 1.9%; P =0.32), and favorable discharge location (85% versus 89%; P =0.37). Conclusions—: A streamlined hMRI protocol permitted tPA administration to a small, but significant, subset of AIS patients initially considered to have SM.